IN VITRO DIAGNOSTICS Mergers & Acquisitions Luminex Corp. Nanosphere Inc. Luminex Corp. is paying $77mm ($1.70 per share; a 63% premium) in cash to acquire molecular diagnostics firm Nanosphere
Company Changes AGRAWAL , Amit To: Bellerophon Therapeutics Inc. , COO (July) From: Amgen Inc., Dir., Strategy & Corp. Dev. Phone: 908-574-4770 ARMOUR , Alison A., MD To: Endocyte Inc. , C
New At The Helm Company Changes AGRAWAL , Amit To: Bellerophon Therapeutics Inc. , COO (July) From: Amgen Inc., Dir., Strategy & Corp. Dev. Phone: 908-574-4770 ARMOUR , Alison A., MD To: En